CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2024	$ 4	$ 403,024	$ (431,597)	$ (28,569)
Balance at beginning (in shares) at Dec. 31, 2024	555,511
Net Income (Loss)			9,095	9,095
Issuance of shares and reclassification of liability related to cashless warrant exercises	$ 5	6,417		6,422
Issuance of shares and reclassification of liability related to cashless warrant exercises (in shares)	9,983,104
Stock-based compensation expense		1,729		1,729
Balance at the ending at Mar. 31, 2025	$ 9	411,170	(422,502)	(11,323)
Balance at ending (in shares) at Mar. 31, 2025	10,538,615
Balance at the beginning at Dec. 31, 2025	$ 9	415,783	(470,819)	$ (55,027)
Balance at beginning (in shares) at Dec. 31, 2025	12,105,902			12,105,902
Net Income (Loss)			(11,793)	$ (11,793)
Issuance of pre-funded warrants related to PIPE financing		13,437		13,437
Issuance of shares related to at-the-market offering, net		1,665		1,665
Issuance of shares related to at-the-market offering, net	1,278,776
Issuance of shares related to exchange of convertible notes	$ 1	31,488		31,489
Issuance of shares related to exchange of convertible notes (in shares)	11,918,380
Modification of cash-settled restricted stock units		1,952		1,952
Stock-based compensation expense		1,525		1,525
Balance at the ending at Mar. 31, 2026	$ 10	$ 465,850	$ (482,612)	$ (16,752)
Balance at ending (in shares) at Mar. 31, 2026	25,303,058			25,303,058